Partition dimension of COVID antiviral drug structures.

Autor: Khabyah AA; Department of Mathematics, College of Science, Jazan University, New Campus, Jazan 2097, Saudi Arabia., Jamil MK; Department of Mathematics, Riphah Institute of Computing and Applied Sciences, Riphah International University Lahore, Pakistan., Koam ANA; Department of Mathematics, College of Science, Jazan University, New Campus, Jazan 2097, Saudi Arabia., Javed A; Abdus Salam School of Mathematical Sciences, Government College University, Lahore, Pakistan., Azeem M; Department of Mathematics, Riphah Institute of Computing and Applied Sciences, Riphah International University Lahore, Pakistan.
Jazyk: angličtina
Zdroj: Mathematical biosciences and engineering : MBE [Math Biosci Eng] 2022 Jul 15; Vol. 19 (10), pp. 10078-10095.
DOI: 10.3934/mbe.2022471
Abstrakt: In November 2019, there was the first case of COVID-19 (Coronavirus) recorded, and up to 3$ ^{rd }$ of April 2020, 1,116,643 confirmed positive cases, and around 59,158 dying were recorded. Novel antiviral structures of the SARS-COV-2 virus is discussed in terms of the metric basis of their molecular graph. These structures are named arbidol, chloroquine, hydroxy-chloroquine, thalidomide, and theaflavin. Partition dimension or partition metric basis is a concept in which the whole vertex set of a structure is uniquely identified by developing proper subsets of the entire vertex set and named as partition resolving set. By this concept of vertex-metric resolvability of COVID-19 antiviral drug structures are uniquely identified and helps to study the structural properties of structure.
Databáze: MEDLINE